Evidence map›Paper›PMID 35603782›Full record

ArticleACR open rheumatology2022

Mental Health Care Use and Associated Factors in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.

Karima Becetti, Joseph T Nguyen, Linda Kwakkenbos, Marie-Eve Carrier, Lydia Tao, Jessica K Gordon, Carol A Mancuso, Joep Welling, Luc Mouthon, Susan J Bartlett and 4 more

Open access · goldAbstract read
In one paragraph

Article in ACR open rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 6 countries.

Karima BecettiHamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0002-0715-2993
Joseph T NguyenHospital for Special Surgery, New York City, New York.
Linda KwakkenbosBehavioural Science Institute, Radboud University, Nijmegen, the Netherlands.
Marie-Eve CarrierLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Lydia TaoLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Jessica K GordonHospital for Special Surgery, New York City, New York.ORCID https://orcid.org/0000-0001-8068-0592
Carol A MancusoHospital for Special Surgery, New York City, New York.ORCID https://orcid.org/0000-0003-1800-570X
Joep WellingDutch Patient Organization for Systemic Autoimmune Diseases, Utrecht, the Netherlands, and Federation of European Scleroderma Associations, Brussels, Belgium.
Luc MouthonUniversité Paris Descartes, Assistance Publique-Hôpitaux de Paris, and Hôpital Cochin, Paris, France.
Susan J BartlettMcGill University and McGill University Health Center Research Institute, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0001-9755-2490
Vanessa L MalcarneSan Diego State University, San Diego, California.
Brett D ThombsLady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0002-5644-8432
Robert F SpieraHospital for Special Surgery, New York City, New York.ORCID https://orcid.org/0000-0003-2911-6800
Scleroderma Patient-Centered Intervention Network Investigators
Hospital for Special Surgery · US

Funding

Arthritis SocietyCIHRJewish General Hospital FoundationLady Davis Institute for Medical Research of the Jewish General HospitalMcGill UniversityScleroderma Association of BCScleroderma AtlanticScleroderma AustraliaScleroderma CanadaScleroderma ManitobaScleroderma New South WalesScleroderma QueenslandScleroderma SASKScleroderma Society of OntarioScleroderma VictoriaSclérodermie QuébecThombs is supported by a Tier 1 Canada Research Chair
6 · The paper itself

Abstract

objectiveSystemic sclerosis (SSc) has significant psychosocial implications. We aimed to evaluate the proportion of participants in a large international SSc cohort who used mental health services in a 3-month period and to evaluate demographic, psychological, and disease-specific factors associated with use.

methodsBaseline data of participants enrolled in the Scleroderma Patient-Centered Intervention Network Cohort were analyzed. We determined the proportion that used mental health services and the source of services in the 3 months prior to enrollment. Multivariable logistic regression was used to identify variables associated with service use.

resultsOf the 2319 participants included in the analysis, 417 (18%) used mental health services in the 3 months prior to enrollment. General practitioners were the most common mental health service providers (59%), followed by psychologists (25%) and psychiatrists (19%). In multivariable analysis, mental health service use was independently associated with higher education (odds ratio [OR] 1.07, 95% confidence interval [CI] 1.03-1.11), smoking (OR 1.06, 95% CI 1.02-1.11), being retired (OR 0.60, 95% CI 0.38-0.93), having limited SSc (OR 1.39, 95% CI 1.02-1.89), and having higher anxiety symptom scores (OR 1.04, 95% CI 1.03-1.06) and lower self-efficacy scores (OR 0.90, 95% CI 0.83-0.97). Variables not significantly associated included age, race, disease manifestations, depression symptom scores, and body image distress.

conclusionAbout 18% of participants in a large international cohort received mental health services in a 3-month period, of whom the majority received these services from a general practitioner.

Identifiers

PMID35603782
PMCPMC9374049
OpenAlexW4281388774

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.